One disclosure schedule line item that decided a Richmond Hill acquisition

The situation

The entry was two sentences long, buried on page eleven of a disclosure schedule sent over on a Friday afternoon: a batch of a manufactured component, produced roughly a year earlier, had shown an elevated failure rate in the field, and the seller was 'monitoring the situation.' Nothing else. No number of units affected, no estimate of exposure, no mention of whether customers had complained or claims had been made.

Carlos, a principal at a mid-market acquisition company, had spent months working toward a deal to buy a Richmond Hill business that manufactured components for industrial equipment, with his business partner Sofia handling much of the financial due diligence. The transaction, valued in the eight to fifteen million dollar range, was close to signing when that disclosure schedule entry arrived. Carlos had come up through operations roles before founding the acquisition company, and Sofia had built her career keeping other people's books before joining him; neither had a legal background, but both understood immediately that a defect described in two vague sentences could mean almost anything. They had already spent considerable time and money on diligence, and the deal was close enough to signing that walking away entirely felt like an overreaction, at least until they understood what the entry actually meant.

The seller's representative, Ishara, downplayed the entry when asked about it directly, describing it as a minor and already-resolved manufacturing issue that the seller's engineering team had corrected months earlier. She pushed to keep negotiations moving toward the agreed closing date and resisted requests to slow down for a deeper technical review, framing further diligence as an unnecessary delay over something already handled. Her tone suggested mild irritation that the buyers were treating a settled matter as a live one, which, for a time, made Carlos and Sofia second-guess their own instinct to dig further.

The purchase agreement, as drafted, treated the defect like any other breach of the ordinary representations: it would share the deal's general indemnity cap, the ceiling that applied to that class of claim, rather than sitting outside it the way fundamental matters like title to the shares, tax and fraud usually did. If the defect turned out to be larger than described, and if other ordinary claims arose too, such as an unrelated employment matter or a breach of an operational representation, Carlos and Sofia's company could find its total recovery for all of them capped well below the actual cost of the problem, with no way to recover more even if the defect alone justified it. The general cap had been negotiated with ordinary post-closing risk in mind, not a known issue sitting quietly in a schedule.

Why this was harder than it looked

On its face, asking for a specific indemnity for a known issue sounds simple: carve it out, give it its own cap, move on. In practice, the seller's early tactical decision to minimize the entry rather than negotiate its terms openly created the opening that mattered most, but it also made the negotiation harder in a different way. Because Ishara had characterized the defect as minor and resolved, any request for a large, uncapped specific indemnity risked looking like it contradicted her own description of the problem, and the seller could reasonably ask why a 'minor, resolved' issue needed special treatment at all. That tension shaped almost every conversation that followed: we needed language firm enough to actually protect Carlos and Sofia if the defect turned out to be serious, while staying credible against a seller who kept insisting, with apparent sincerity, that it was not.

The real difficulty was pricing the unknown. Nobody, including the seller, had a reliable estimate of how many units were affected, how many had already failed, or what a full product recall or customer settlement program might eventually cost. A specific indemnity needs a cap and a survival period, both of which are easier to negotiate when the underlying risk has a knowable range. Here, the range was, by the seller's own account, small, but by any independent assessment, unverified.

There was also a timing problem. The deal's general representations and warranties were set to survive for a standard period after closing, generally adequate for most claims. A defect that surfaces gradually in the field, however, sometimes does not fully reveal its scope within that window; failures can accumulate over a longer period as more units reach the end of their working life. A short survival period on the specific indemnity would have protected the seller more than it protected the buyer, since most claims arising from a slow-developing failure pattern would simply not yet exist by the time a standard window closed.

Finally, Ishara's insistence on staying close to the original closing date meant there was limited time to commission independent technical review of the defect before terms had to be locked in, forcing much of the negotiation to happen around assumptions rather than confirmed facts. Every extra day spent verifying the seller's claims was a day the seller's advisors framed as evidence that Carlos and Sofia did not trust a deal they had otherwise been eager to close, adding a layer of relationship pressure to what was already a technically difficult negotiation.

What we did

1. Treated the vague disclosure as a red flag, not a resolved issue. Rather than accepting Ishara's characterization at face value, we advised Carlos and Sofia to request the underlying engineering and customer complaint records referenced by the disclosure. The seller's own casual framing made that request harder to refuse without appearing inconsistent, and although the records that came back were incomplete, even that partial picture was enough to show the entry had understated how many complaints existed.
2. Commissioned a limited, focused technical review. To avoid a full-blown independent audit that would have blown through the closing timeline, we worked with Carlos and Sofia to identify a narrower, faster review of the specific component batch. That scoped review gave them independent information to negotiate from evidence rather than the seller's assurances alone, without handing the seller a reason to accuse them of stalling the deal.
3. Used the seller's own words against a low cap. Because Ishara had repeatedly described the issue as minor, we argued that a modest specific indemnity cap, set above the seller's own stated estimate of exposure but below the general deal cap, cost the seller little if her characterization was accurate. That framing turned her own dismissiveness into the very reason she had limited room to resist the number.
4. Negotiated a longer, defect-specific survival period. We separated the specific indemnity's time limit from the general representations, arguing for a period long enough to capture failures that might surface gradually as more affected units reached end of life, rather than the shorter standard window that governed the rest of the deal. Without that extension, a claim arising in month ten could have been time-barred before the failure pattern was even visible.
5. Built a step-down deductible instead of a flat threshold. To keep the seller engaged in negotiating reasonably rather than stonewalling, we proposed a lower dollar threshold before the specific indemnity applied, compared to the general indemnity's threshold, reflecting that this was a known, not a newly discovered, risk that did not deserve the same buffer as an ordinary surprise claim.
6. Required an update obligation before closing. We added a covenant requiring the seller to disclose any material developments regarding the defect between signing and closing, so that a worsening situation could not be discovered only after the deal had already closed and any remedy had become far more difficult to pursue. It also gave Carlos and Sofia a documented basis to walk away or renegotiate if the picture changed materially before the transaction became final.
7. Kept the escrow proportionate to the specific cap. We negotiated a holdback amount tied specifically to the defect indemnity's cap, held separately from the general escrow, so that a claim under one would not be constrained by activity under the other and each recovery path stayed clean and independently enforceable. That separation is what later let the recall claim draw against its own fund without competing against unrelated post-closing issues.
8. Documented the negotiation history in the agreement's recitals. We made sure the final agreement clearly reflected that the specific indemnity addressed a disclosed, known issue, distinct from the general indemnity's coverage of unknown risks, so that if a dispute ever arose over which provision applied, the contract itself would settle the question rather than leaving it to competing recollections of what had been intended months earlier.
9. Reviewed the interplay with the general representations. We confirmed that the general representation and warranty covering product quality was not accidentally duplicating, or worse, undercutting, the specific indemnity's coverage. Overlapping provisions with different caps can create ambiguity about which one actually governs a given claim, and resolving that ambiguity before signing is far cheaper than litigating it after a claim has already arisen.

The outcome

The deal closed with the specific indemnity in place: its own cap, its own longer survival period, its own dedicated holdback, all separate from the general indemnity structure covering the rest of the transaction. Roughly eight months after closing, the defect turned out to be more widespread than Ishara had described, with failure reports continuing to arrive from customers and a partial product recall becoming necessary across a larger share of the affected batch than the original disclosure had suggested.

Because the indemnity had been carved out with its own cap set above the seller's original estimate, Carlos and Sofia's company was able to recover a meaningful portion of the recall and remediation costs from the dedicated escrow, without that recovery competing against or exhausting the general indemnity available for any other post-closing issues that surfaced separately. The dedicated cap, however, was not unlimited, and the eventual cost of the defect exceeded it. The company absorbed the difference itself, funding the shortfall out of the acquired business's own operating cash flow rather than through any further claim against the seller. That shortfall was real money, and it delayed a planned expansion the acquired business had been budgeting for, but it did not threaten the business's viability the way an uncapped, unrecovered loss might have.

This was a contained loss, not an avoided one. Carlos described the outcome afterward as the deal working the way it was supposed to: a known risk had been priced and capped in advance rather than discovered as an open-ended surprise after closing, and the recovery, while partial, meant the defect did not become a loss the company had to bear entirely on its own. Sofia, reviewing the numbers afterward, pointed out that without the separate cap and holdback, the recall costs would have had to compete against every other post-closing claim for a share of the same general limit, likely leaving far less available for either.

What you can learn from this